Product Description

The product stops bleeding quickly, effectively and reliably, with no biological risk in vivo and free from side effects.

This line of products is porous microspheres made from plant starch with a number of patent technologies, such as emulsification and reverse crosslinking. MPH, the flagship product of the company belongs to the project subsidized by the Natonal Innovation Fund, and the company owns all the intellectual property rights of the product.

The product stops bleeding quickly, effectively and reliably, with no biological risk in vivo and free from side effects. The product can be completely degraded and absorbed in the body, and thus can be applied to the bleeding surface of a wound. With its granular molecules absorbing rapidly the moisture from the blood and gathering the visible components (such as platelets, red blood cells, albumin, thrombin and fibrin, etc.) in the blood at the surface of particles to form a gelatinous mixture, the product stops the bleeding immediately. Meanwhile, it speeds up the activation of endogenous hemostatic factors, shortening the clotting process and forming solid and reliable local blood clot, stopping bleeding within several seconds. The gels formed can be decomposed by the amylase in the humor into maltose or glucose within 10 days after the completion of hemostasis, ad the maltose or glucose can be completely absorbed in the body. The absorption process begins with the completion of the hemostasis, without leaving any traces locally.

Scope of application:

Specification